We searched The Cancer Genome Atlas (TCGA) database for viruses by comparing non-human reads present in transcriptome sequencing (RNA-Seq) and whole-exome sequencing (WXS) data to viral sequence databases. Human papillomavirus 18 (HPV18) is an etiologic agent of cervical cancer, and as expected, we found robust expression of HPV18 genes in cervical cancer samples. In agreement with previous studies, we also found HPV18 transcripts in non-cervical cancer samples, including those from the colon, rectum, and normal kidney. However, in each of these cases, HPV18 gene expression was low, and single-nucleotide variants and positions of genomic alignments matched the integrated portion of HPV18 present in HeLa cells. Chimeric reads that match a known virus-cell junction of HPV18 integrated in HeLa cells were also present in some samples. We hypothesize that HPV18 sequences in these non-cervical samples are due to nucleic acid contamination from HeLa cells. This finding highlights the problems that contamination presents in computational virus detection pipelines.
I
n 1951, a biopsy specimen was taken from a cervical adenocarcinoma of Henrietta Lacks. The first immortal human cancer cell line, called HeLa (1), was produced from this tissue. HeLa was the only human cancer cell line available at the time, and because of its growth potential, it was widely distributed to laboratories around the world. Subsequently, HeLa rapidly outgrew many cell lines (2, 3) . Cross-contamination was even suspected from air droplets (4) . Evidence of widespread contamination eventually turned into a controversy that is still unsettled today (5, 6) . More than 50 years later, HeLa cell contamination is still being uncovered in cell lines (7) and the problem of cell line contamination is not limited to HeLa (8, 9) .
Human papillomavirus 18 (HPV18) is integrated in the HeLa genome (10) . Three segments of HPV18 are integrated at a known fragile site on chromosome 8 (locus 8q24) which is located approximately 500 kb upstream of the myc gene. The integrated portion of HPV18 includes genomic regions from bases 1 to 3088 and 5736 to 7857 (11) of the reference genome, and thus contains the long control region (LCR), the E6, E7, and E1 genes, and partial coding regions for the E2 and L1 genes. The E4, E5, and L2 genes are deleted. The integration causes a truncation in the E2 gene, a negative regulator of viral E6 and E7 expression (12) , thereby allowing transcriptional activation of the E6 and E7 oncogenes. In addition, the integrated HPV18 sequence differs from the reference genome at 23 base positions (13) .
Human papillomaviruses are found in almost every case of cervical cancer. HPV16 and HPV18 are the primary etiological agents, accounting for 70% of all cases (14, 15) . High-risk HPV has also been detected in colorectal samples, but these findings remain controversial (16) (17) (18) . Recently, HPV18 has been detected in colorectal samples and a normal kidney sample in The Cancer Genome Atlas (TCGA) database (19, 20) . In these reports, the pattern of viral transcription is indicative of oncogenic integration. TCGA collates large-scale genome sequencing of thousands of tumor samples from more than 30 human cancers. This large pool of sequencing data has afforded an unprecedented opportunity for the research community to search for viruses in human tissue. We are searching the TCGA database for the presence of known and novel viruses. Here, we report on the authenticity of HPV18 sequences and the apparent HeLa cell contamination in some TCGA samples.
MATERIALS AND METHODS
Cancer databases. The results published here are in whole based upon data generated by The Cancer Genome Atlas (TCGA) Research Network (http://cancergenome.nih.gov/). All human data were handled in accordance with a Data Access Request between the University of Pittsburgh and the NIH for dbGaP study accession number phs000178. Selected transcriptome sequencing (RNA-Seq) and whole-exome sequencing (WXS) BAM files were downloaded with GeneTorrent (http://cghub.ucsc .edu) and handled in accordance with the TCGA Data Use Certification Agreement (version 9/12/2013). BAM files are the binary format of the sequencing alignment map (SAM) format (http://samtools.github.io/hts -specs/SAMv1.pdf).
Computational pipeline for virus detection. Non-human reads from TCGA BAM files were extracted and processed with prinseq-lite.pl (21) with the command line options "-lc_method entropy -lc_threshold 60 -min_qual_mean 15 -ns_max_p 5 -trim_qual_right 10 -trim_qual_left 10 -min_len 30" to trim and remove poor-quality sequences. High-quality reads were mapped to the Viral RefSeq (VRS) database (ftp://ftp.ncbi.nlm .nih.gov/refseq/release/viral/; downloaded December 2012) with Bowtie 2 (http://bowtie-bio.sourceforge.net/bowtie2/index.shtml; 22). Bowtie 2 is a very fast aligner of short sequences (such as those generated in highthroughput sequencing) to long sequences, such as the human genome. VRS-mapped reads were additionally filtered by mapping them with Bowtie 2 to the human genome 19 (hg19) database. Finally, all hg19-unmapped reads were remapped to VRS with Bowtie 2 to create a set of raw virus alignments. All Bowtie 2 commands used default options except that the "--very-sensitive" option was used. HPV18 was considered detected in a TCGA BAM file if the number of alignments to the virus was Ն10.
Single-nucleotide variant analysis. A list of 23 single-nucleotide variant (SNV) sites that differ between the HPV18 sequence found in HeLa cells (GenBank accession number U89349) and the HPV18 reference sequence was constructed. This list and virus alignments were input into a Perl script to tabulate various statistics on the number of alignments and SNVs detected relative to the HPV18 reference genome. Virus alignments (in BAM format) were visualized with IGV (23) . IGV is a popular visualization tool for exploring high-throughput sequencing experiments. For the TCGA analysis identifiers used, see Table 2 .
Chimera analysis. SummonChimera (24) was used to search for chimeric reads between HPV18 and the human genome. Reads from a sample were aligned to HPV18 and hg19 with BLASTN. The BLASTN output files and the virus alignments were input into SummonChimera. SummonChimera was run with the default parameters. The samples used were the same as those for the single-nucleotide variant analysis.
G6PD SNP analysis. The HeLa cell genome contains single-nucleotide polymorphism (SNP) rs1050829, which represents a change from T to a C on chromosome X at position 153,763,492 in hg19. SAMtools mpileup was used to generate the depth of reads at this position, and the frequency of SNP rs1050829 was calculated.
HPV18 strain analysis. Variant calls for each sample were generated with the mpileup program of SAMtools (version 0.1.19; http://samtools .sourceforge.net/) for HPV18 (GenBank accession number NC_ 001357.1). SAMtools is a collection of utility programs to manipulate and summarize the alignments of high-throughput sequence data to a reference sequence (25) . The variant calls were used to build a consensus HPV18 genome for each sample. A base position was considered mutated if the majority base at that position is not the reference base. The consensus HPV18 genomes were aligned with BLASTN (ftp://ftp.ncbi.nlm.nih .gov/blast/executables/blastϩ/) to the set of 124 alphapapillomavirus 7 complete genomes (NCBI Nucleotide database query, "alphapapillomavirus 7 complete genome") with default parameters.
RESULTS
HPV18 sequences are detected in human cancers. While exploring TCGA databases for viral sequences (P. G. Cantalupo, J. P. (Tables 1 and 2 ). As expected, HPV18 transcription was detected in many cervical cancer (cervical squamous cell carcinoma; CESC) RNA-Seq samples (34 out of 109). A few of these had more than 100,000 alignments, and several samples had almost complete coverage of the HPV18 genome. We found RNA-Seq reads aligning to HPV18 in 39 other samples from 9 non-CESC cancers ( Table 1 ). The maximum number of alignments to HPV18 in these samples was 1,896. We confirmed the presence of HPV18 in many of the CESC RNA-Seq samples by WXS, but we were unable to detect HPV18 by WXS for the remaining cancers. Alignments in non-CESC samples are similar to the integrated portion of HPV18 in HeLa cells. We questioned the presence of HPV18 in non-CESC samples for several reasons. First, the number of alignments to HPV18 was much lower in non-CESC samples. Second, upon closer examination, we noticed that the sequences aligning to HPV18 in non-CESC samples contained single-nucleotide variants relative to the reference genome and lacked aligned reads to the central region of the viral genome (coordinates 3089 to 5735) that encodes the E2, E4, E5, and L2 genes (Fig. 1 ). Both these variants (Table 3 ) and the deleted central region are indicative of the partial HPV18 genome that is integrated into HeLa cells (11, 13) . We hypothesized that the HPV18 detected in the non-CESC samples came from HeLa nucleic acid contamination. To test this, we conducted several analyses described below.
HeLa-HPV18 single-nucleotide variant analysis. There are 23 bases that differ between the integrated region of HPV18 in the HeLa genome (GenBank accession number U89349 [13] ) and the reference sequence (Table 3) . Four CESC samples and two non-CESC samples (1 head-and-neck squamous cell carcinoma [HNSC] and 1 lung squamous cell carcinoma [LUSC] sample) did not have any reads that overlap these variant sites; therefore, they were removed from further analysis. A heat map was generated for 
acc62c2f-5bde-4d4e-807a-e2bf8773b49d COAD b2fb6250-c37c-4d34-b657-853b3fa2f2fd COAD b3fe0f6b-e750-4290-83db-533e93580585 COAD d134c76e-83a5-48d7-af48-5105c10a506c COAD ef5879a7-7bef-488f-b247-3f1f57b5841a COAD f4fe6fc4-f663-42df-89d1-e5991b3c32a0 HNSC 9bbf6a87-5add-462a-9720-67dbd295b8ff KIRC a6e8fee6-753f-4b33-8610-9efa61246abb KIRP 72fe472f-7c9a-4f53-aef1-31c741d23d5a KIRP 833f7265-fa2c-45d6-82d1-37751aec60f4 LIHC 36fbc8a1-0cea-4ceb-ae61-3a026b613f5e the remaining 67 samples (Fig. 1B) , showing the percentage of reads that contain the HeLa allele at each of the 23 HeLa variant positions. In all non-CESC samples, the HeLa allele frequency was 100% at positions covered by at least one read. Additionally, the same samples did not have any reads that aligned to the deleted region of HPV18 in HeLa (Fig. 1A and data not shown). In contrast, the CESC samples displayed a range of HeLa allele frequencies of from 0% to 100% (Fig. 1B) . In addition, 30 CESC samples (83%) had alignments to the deleted region (Fig. 1A and data not shown). HeLa-HPV18 specific junctions were detected in non-CESC samples. We hypothesized that if HeLa nucleic acids were present in the non-CESC samples, then a subset should include virushuman chimeric reads that match the known integration sites of HPV18 in HeLa. We searched for chimeric reads with SummonChimera (24) for all the samples in Fig. 1B . We found chimeric reads that covered a known HPV18-HeLa integration site or a novel junction in the HPV18 integration locus in many (13 out of 37) of the non-CESC samples (Fig. 2) . We did not detect any chimeric reads in the region of chromosome 8 where HPV18 is integrated (128,229,000 to 128,243,000) for the 30 CESC samples. Many of the novel chimeras contain the 929 5= splice site in E1 of HPV18 (26) . Most likely, these chimeras were generated from a splicing event that fused the 929 5= donor to a downstream acceptor site in the human genome. The precise nucleotide match of the cell-virus junction with HeLa is strong evidence that the HPV18 sequences present in these samples represents HeLa cell contamination.
Glucose-6-phosphate dehydrogenase SNP analysis. The historical method to detect HeLa cell contamination was to determine the electrophoretic mobility of the glucose-6-phosphate dehydrogenase (G6PD) gene. It was shown that HeLa possesses the type A ϩ variant of G6PD (2, 27) . The genotype (SNP, rs1050829) corresponding to this phenotype changes T to a C on chromosome X at position 153,763,492 in the human genome. We calculated the frequency of SNP rs1050829 in the samples and found that for the CESC samples, only 2 (6%) had reads that contained the SNP rs1050829 (maximum frequency, 5.4%). For the non-CESC samples, 12 (35%) had reads that contained the SNP rs1050829. The maximum frequency observed was for the kidney clear cell carcinoma (KIRC) sample at 10.7%. We attempted to extend this analysis to globally analyze HeLa-specific SNPs based upon a recent report (28) , but the results were inconclusive mainly due to the low coverage of the SNPs.
HPV18 strain analysis. HPV18 is a member of the Papillomaviridae species Alphapapillomavirus 7. One possibility is that our variant and mapping results could be due to the presence of an alphapapillomavirus 7 strain closely related to HPV18. We tested this hypothesis in two ways. First, we computationally created a consensus HPV18 genome for each sample based upon the variant calls in the sample. The consensus HPV18 genomes were aligned with BLASTN to a set of 124 alphapapillomavirus 7 complete genomes. None of the genomes aligned with 100% identity, and the top hit in all the non-CESC samples is the HPV18 reference sequence (GenBank accession number NC_001357) (data not shown). Second, using BLASTN, we aligned the individual HPV18 reads in each sample to the set of 124 alphapapillomavirus 7 genomes, including an HPV18 genome that was changed at 23 base positions (Table 3) to the HeLa allele (termed HeLa-HPV18). For all the non-CESC samples save one, the genome with the most number of reads that aligned to it with 100% identity was the HeLa-HPV18 genome (data not shown). Therefore, from both these analyses, we conclude that the presence of a strain closely related to HPV18 is not present in non-CESC samples.
HeLa contamination was restricted to two sequencing centers and specific time periods. We correlated the presence of HeLa contamination with several TCGA parameters, such as analysis date, year, sequencing machine, sequencing center, tissue source site, and sample type (tumor or normal). Contamination was limited to several dates and two sequencing centers that perform RNA-Seq for the TCGA, the University of North Carolina Lineberger Comprehensive Cancer Center (UNC-LCCC) and the British Columbia Cancer Agency's Michael Smith Genome Sciences Centre (BCCAGSC) (data not shown). All of the contamination occurred in 2011 (8% of the samples) and 2012 (0.5% of the samples). No contamination was detected in samples pro- 
DISCUSSION
Is it HPV18 or HeLa? In this report, we analyzed TCGA RNA-Seq and whole-exome sequencing (WXS) data sets to determine the presence of HPV18 in a variety of tumors. As expected, HPV18 was detected in many CESC samples. HPV18 was also detected in 9 other cancers. However, our analyses show that these alignments match the portion of the HPV18 genome that is integrated into the HeLa genome and do not represent a different strain of HPV18. In contrast to previous reports, our data suggest that HPV18 is not present in the non-CESC samples, such as the colon adenocarcinoma, rectum adenocarcinoma (READ), and normal kidney samples, as previously reported (19, 20) . These findings are most likely explained by contamination with HeLa nucleic acids during sample procurement, preparation, or sequencing.
HeLa contamination was present in two TCGA sequencing centers. The HeLa contamination was limited to the UNC-LCCC and BCCAGSC RNA sequencing centers during the years 2011 and 2012. The WXS samples that we analyzed were sequenced at the Baylor College of Medicine (BCM), Broad Institute (BI), and Washington University Genome Sequencing Center (WUGSC). Therefore, it is not surprising that we only detected HPV18 by WXS in CESC samples. A recent study reported that HPV18 was not present in whole-genome sequencing (WGS) of the same COAD and READ samples for which HPV18 was detected in the corresponding RNA-Seq analyses (20) . These results make sense in light of the fact that none of the TCGA WXS and WGS samples were sequenced in the centers (UNC-LCCC and BCCAGSC) where HeLa contamination was found.
Other contamination in TCGA databases. There are several examples of DNA contamination in TCGA. Tang et al. (19) have reported that a kidney clear cell carcinoma (KIRC) sample having alignments to hepatitis B virus came from contamination from a liver hepatocellular carcinoma (LIHC) sample. In addition, they report the contamination of plasmids containing the cytomegalovirus (CMV) promoter in many samples. In another report, a step was added to their analysis pipeline to specifically reduce the vector contamination problem (20) . During the course of our analysis, we confirmed these contaminations and identified several others. For example, we found that Dengue virus 2 (DV2) was present in two ovarian cancer (OV) tumor samples (ϳ250 alignments each). BLASTN searches of several of these reads matched with 100% identity to two DV2 isolates (GenBank accession numbers FJ906962.1 and FJ850121.1) (data not shown). Both accession numbers are annotated in GenBank as "Broad Institute Genome Sequencing Platform; Broad Institute Microbial Sequencing Center; Genome Resources in Dengue Consortium." Because the Broad Institute has a Dengue virus project, we believe that these sequences are not truly present in the OV samples but rather are cross-contamination from BI sequencers. Next-generation sequencing (NGS) artifacts are not limited to TCGA. For instance, contamination of an ovarian cancer cell line with 293T cells led to the misidentification of viruses in the ovarian cancer cell line (29) . Finally, as seen in our G6PD analysis, contamination of nucleic acids has the potential to introduce a population of reads containing cellular mutations which, depending upon the level of contamination and depth of sequencing, may affect variant calls.
Conclusion. Nucleic acid contamination occurs frequently during experimentation at the bench. Most of the time this contamination is not detected, but with the advent of sensitive techniques such as PCR and deep sequencing, the contamination that was once hidden is suddenly revealed. We have shown that HeLa nucleic acid contamination (and the other contaminations described above) can lead to the misidentification of viruses. This presents a major challenge for accurately identifying viruses from NGS data, whether the samples are cancer tissues or normal tissues used for microbiome studies. We now add HeLa cell contamination to the growing list of artifacts that should be accounted for when analyzing human sequencing data for the presence of viruses.
